Microvascular disease in children and adolescents with type 1 diabetes and obesity (Q37780987)

23 August 2017

title

Microvascular disease in children and adolescents with type 1 diabetes and obesity (English)

1 reference

23 August 2017

0 references

0 references

1 reference

0 references

M Loredana Marcovecchio

series ordinal

1

1 reference

23 August 2017

Francesco Chiarelli

series ordinal

2

1 reference

23 August 2017

publication date

19 August 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

26

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

365-375

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

23 August 2017

1 reference

Type 2 diabetes mellitus in youth: the complete picture to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Lifetime Risk for Diabetes Mellitus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Early diabetes-related complications in adolescents: risk factors and screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Microalbuminuria as prediction of nephropathy in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Regression of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

The case for biennial retinopathy screening in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Diabetic neuropathy in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Recent advances in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Diabetic microvascular complications--can the presence of one predict the development of another?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Age at onset and the risk of proliferative retinopathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Maternal but not paternal association of ambulatory blood pressure with albumin excretion in young offspring with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Management of diabetic retinopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Should Angiotensin converting enzyme inhibitors be used in children with type 1 diabetes and microalbuminuria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Worldwide trends in childhood overweight and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

21 January 2018

Obesity and eye diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Assessment of Cardiac Autonomic Modulation during Adolescent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Obesity and autonomic function in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Acute and chronic complications of type 2 diabetes mellitus in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Comorbidities and microvascular complications of type 2 diabetes in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

C-Reactive Protein in Relation to the Development of Microalbuminuria in Type 1 Diabetes: The Oxford Regional Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Unchanged incidence of microalbuminuria in children with type 1 diabetes since 1986: a UK based inception cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1624-9

Do all prepubertal years of diabetes duration contribute equally to diabetes complications?

21 January 2018

1 reference

12 December 2020

Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians

1 reference

12 December 2020

Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes.

1 reference

12 December 2020

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

1 reference

12 December 2020

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

1 reference

12 December 2020

Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes

1 reference

12 December 2020

Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

12 December 2020

Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies.

1 reference

12 December 2020

Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland

1 reference

12 December 2020

Long-term glycemic control and the rate of progression of early diabetic kidney disease

1 reference

12 December 2020

The natural history of microalbuminuria in adolescents with type 1 diabetes

1 reference

12 December 2020

Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes

1 reference

12 December 2020

Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood Diabetes.

1 reference

12 December 2020

Obesity in children and adolescents

1 reference

12 December 2020

Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

1 reference

12 December 2020

From diagnosis and classification to complications and therapy. DCCT. Part II? Diabetes Control and Complications Trial

1 reference

12 December 2020

Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II

1 reference

12 December 2020

Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S00467-010-1624-9

Identifiers

DOI

1 reference

23 August 2017

1 reference